5′-Cytimidine Monophosphate Ameliorates H<sub>2</sub>O<sub>2</sub>-Induced Muscular Atrophy in C2C12 Myotubes by Activating IRS-1/Akt/S6K Pathway

Age-related muscle atrophy (sarcopenia), characterized by reduced skeletal muscle mass and muscle strength, is becoming increasingly prevalent worldwide, which is especially true for older people, and can seriously damage health and quality of life in older adults. This study aims to investigate the...

Full description

Bibliographic Details
Main Authors: Xin Wu, Na Zhu, Lixia He, Meihong Xu, Yong Li
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/13/2/249
_version_ 1797299017721315328
author Xin Wu
Na Zhu
Lixia He
Meihong Xu
Yong Li
author_facet Xin Wu
Na Zhu
Lixia He
Meihong Xu
Yong Li
author_sort Xin Wu
collection DOAJ
description Age-related muscle atrophy (sarcopenia), characterized by reduced skeletal muscle mass and muscle strength, is becoming increasingly prevalent worldwide, which is especially true for older people, and can seriously damage health and quality of life in older adults. This study aims to investigate the beneficial effects of 5′-cytimidine monophosphate (CMP) on H<sub>2</sub>O<sub>2</sub>-induced muscular atrophy in C2C12 myotubes. C2C12 myotubes were treated with H<sub>2</sub>O<sub>2</sub> in the presence and absence of CMP and the changes in the anti-oxidation, mitochondrial functions, and expression of sarcopenia-related proteins were observed. Immunofluorescence analysis showed that CMP significantly increased the diameter of myotubes. We found that CMP could increase the activity of antioxidant enzymes and improve mitochondrial dysfunction, as well as reduce inflammatory cytokine levels associated with sarcopenia. RNA-seq analysis showed that CMP could relieve insulin resistance and promote protein digestion and absorption. Western blot analysis further confirmed that CMP could promote the activation of the IRS-1/Akt/S6K signaling pathway and decrease the expression of MuRF1 and Atrogin-1, which are important markers of muscle atrophy. The above results suggest that CMP protects myotubes from H<sub>2</sub>O<sub>2</sub>-induced atrophy and that its potential mechanism is associated with activating the IRS-1/Akt/S6K pathway to promote protein synthesis by improving mitochondrial dysfunction and insulin resistance. These results indicate that CMP can improve aging-related sarcopenia.
first_indexed 2024-03-07T22:44:29Z
format Article
id doaj.art-56b9d9647ec84216ae5bfeccde741266
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-07T22:44:29Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-56b9d9647ec84216ae5bfeccde7412662024-02-23T15:05:37ZengMDPI AGAntioxidants2076-39212024-02-0113224910.3390/antiox130202495′-Cytimidine Monophosphate Ameliorates H<sub>2</sub>O<sub>2</sub>-Induced Muscular Atrophy in C2C12 Myotubes by Activating IRS-1/Akt/S6K PathwayXin Wu0Na Zhu1Lixia He2Meihong Xu3Yong Li4Department of Nutrition and Food Hygiene, School of Public Health, Peking University Health Science Center, Beijing 100191, ChinaDepartment of Nutrition and Food Hygiene, College of Public Health, Inner Mongolia Medical University, Hohhot 010059, ChinaDivision of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USADepartment of Nutrition and Food Hygiene, School of Public Health, Peking University Health Science Center, Beijing 100191, ChinaDepartment of Nutrition and Food Hygiene, School of Public Health, Peking University Health Science Center, Beijing 100191, ChinaAge-related muscle atrophy (sarcopenia), characterized by reduced skeletal muscle mass and muscle strength, is becoming increasingly prevalent worldwide, which is especially true for older people, and can seriously damage health and quality of life in older adults. This study aims to investigate the beneficial effects of 5′-cytimidine monophosphate (CMP) on H<sub>2</sub>O<sub>2</sub>-induced muscular atrophy in C2C12 myotubes. C2C12 myotubes were treated with H<sub>2</sub>O<sub>2</sub> in the presence and absence of CMP and the changes in the anti-oxidation, mitochondrial functions, and expression of sarcopenia-related proteins were observed. Immunofluorescence analysis showed that CMP significantly increased the diameter of myotubes. We found that CMP could increase the activity of antioxidant enzymes and improve mitochondrial dysfunction, as well as reduce inflammatory cytokine levels associated with sarcopenia. RNA-seq analysis showed that CMP could relieve insulin resistance and promote protein digestion and absorption. Western blot analysis further confirmed that CMP could promote the activation of the IRS-1/Akt/S6K signaling pathway and decrease the expression of MuRF1 and Atrogin-1, which are important markers of muscle atrophy. The above results suggest that CMP protects myotubes from H<sub>2</sub>O<sub>2</sub>-induced atrophy and that its potential mechanism is associated with activating the IRS-1/Akt/S6K pathway to promote protein synthesis by improving mitochondrial dysfunction and insulin resistance. These results indicate that CMP can improve aging-related sarcopenia.https://www.mdpi.com/2076-3921/13/2/2495′-cytimidine monophosphatesarcopeniamuscular atrophyaging
spellingShingle Xin Wu
Na Zhu
Lixia He
Meihong Xu
Yong Li
5′-Cytimidine Monophosphate Ameliorates H<sub>2</sub>O<sub>2</sub>-Induced Muscular Atrophy in C2C12 Myotubes by Activating IRS-1/Akt/S6K Pathway
Antioxidants
5′-cytimidine monophosphate
sarcopenia
muscular atrophy
aging
title 5′-Cytimidine Monophosphate Ameliorates H<sub>2</sub>O<sub>2</sub>-Induced Muscular Atrophy in C2C12 Myotubes by Activating IRS-1/Akt/S6K Pathway
title_full 5′-Cytimidine Monophosphate Ameliorates H<sub>2</sub>O<sub>2</sub>-Induced Muscular Atrophy in C2C12 Myotubes by Activating IRS-1/Akt/S6K Pathway
title_fullStr 5′-Cytimidine Monophosphate Ameliorates H<sub>2</sub>O<sub>2</sub>-Induced Muscular Atrophy in C2C12 Myotubes by Activating IRS-1/Akt/S6K Pathway
title_full_unstemmed 5′-Cytimidine Monophosphate Ameliorates H<sub>2</sub>O<sub>2</sub>-Induced Muscular Atrophy in C2C12 Myotubes by Activating IRS-1/Akt/S6K Pathway
title_short 5′-Cytimidine Monophosphate Ameliorates H<sub>2</sub>O<sub>2</sub>-Induced Muscular Atrophy in C2C12 Myotubes by Activating IRS-1/Akt/S6K Pathway
title_sort 5 cytimidine monophosphate ameliorates h sub 2 sub o sub 2 sub induced muscular atrophy in c2c12 myotubes by activating irs 1 akt s6k pathway
topic 5′-cytimidine monophosphate
sarcopenia
muscular atrophy
aging
url https://www.mdpi.com/2076-3921/13/2/249
work_keys_str_mv AT xinwu 5cytimidinemonophosphateameliorateshsub2subosub2subinducedmuscularatrophyinc2c12myotubesbyactivatingirs1akts6kpathway
AT nazhu 5cytimidinemonophosphateameliorateshsub2subosub2subinducedmuscularatrophyinc2c12myotubesbyactivatingirs1akts6kpathway
AT lixiahe 5cytimidinemonophosphateameliorateshsub2subosub2subinducedmuscularatrophyinc2c12myotubesbyactivatingirs1akts6kpathway
AT meihongxu 5cytimidinemonophosphateameliorateshsub2subosub2subinducedmuscularatrophyinc2c12myotubesbyactivatingirs1akts6kpathway
AT yongli 5cytimidinemonophosphateameliorateshsub2subosub2subinducedmuscularatrophyinc2c12myotubesbyactivatingirs1akts6kpathway